Zenith Laboratories Inc company report fourth quarter loss amount determine completion audit. The company elaborate further. For third quarter end Sept 30 1986 Zenith report loss 3451000 dlrs 16 ct share adjust May 1986 2-for-1 stock split. The company receive Food Drug Administration approval market Cefadroxil generic version antibiotic domestic sale exceed 50 mln dlrs 1986. Zenith market drug "questions relate applicability patent resolved." Reuter 